Datasheet: Cell Analysis Suite (CAS™) 2.1 Software
Review our premier software, its key applications, and the features exclusive to the 2.1 upgrade.
Application Note: Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus
Learn how to use blocking and binding assays and the Opto Plasma B Discovery workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.
Application Note: Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow
Learn how to use multiple assays on single T cells to finally understand critical functions, such as serial killing, and how they relate to each other.
Application Note: Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow
Learn how to combine the T Cell Proliferation Assay with either the Multiplex Cytokine Assay or Cytotoxicity Assay to find your most persistent T cells.
Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets Using the Beacon System
Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.
Webinar: Expand and Rapidly Validate Antigen-Specific Function of T Cells Using Fewer Cells
Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.
Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing
Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.
Customer Spotlight: Catalent on CLD
Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.
Webinar: PrimeSeq™ Software — Visualize, Filter, and Analyze Your Single-Cell Genomics Data
Our powerful PrimeSeq software provides valuable insights from your genomics data. Learn how we enable differential expression analysis, quality filters, and more.
Webinar: How Pediatric Immune Systems Empower Cancer Immunotherapy
Dr. David Barrett shares insights into why children’s T cells help CAR-T cells succeed and discusses how the Opto Cell Therapy Development Workflow can provide the detailed characterization required to develop more efficacious therapies.
Webinar: Rapid Discovery of Functional Antibodies for SARS-CoV-2 Using the Beacon System
Robert Carnahan, PhD, and Seth Zost, PhD, from the Vanderbilt University Medical Center, describe how they have used the Beacon platform, to rapidly discover hundreds of unique antibodies against SARS-CoV-2.
SynBioBeta Live Roundtable: Can Humanity Build a Global Antibody Defense Barrier Against Future Pandemics?
Listen to the world’s leading experts on antibody discovery to discuss how we can build a global defensive barrier to find new therapeutic antibodies against the coronavirus and future pathogens.
Webinar: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
Watch this on-demand presentation from the 2020 LabRoots Coronavirus Webinar Series to find out how B Cell Antibody Discovery has allowed Berkeley Lights collaborators to discover >500 antibodies to SARS-CoV-2 in a single day.
Webinar: The New OptoSeq™ Kit – Linking Precious Cell Phenotype to Genotype
Watch this on-demand webinar from Dr. Jason McEwen, our Associate Director of Biology, as he walks you through how our OptoSeq™ Single Cell 3′ mRNA Library Kit will empower you to link differential gene expression data to single precious cells.
Datasheet: Opto Plasma B Discovery 2.0 Workflow
Review workflow overview and representative results.
Brochure: Cell Therapy Development
From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.
Poster: Rapid Generation of Production Cell Lines with Superior Titers and >99% Monoclonality for Complex Antibody Molecules
See how the Opto CLD 2.0 Workflow enables rapid generation of cell lines secreting antibodies for both traditional and non-traditional antibodies while acquiring a superior data package.
Poster: Linking Phenotypic Data to Gene Expression Using the OptoSeq™ Single Cell 3′ mRNA Library Kit
Find out how the OptoSeq™ Single Cell 3′ mRNA Library Kit workflow enables automated, on-chip, bead-based capture of mRNA for reverse transcription, bar-coding, export and direct preparation for NGS.